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maintain the mature chondrocyte phenotype avoiding terminal differentia-
tion towards hypertrophy represents a major issue and is the objective of
this study.
Methods: Bone marrow-derived murine MSCs were induced to differentiate
towards chondrocytes using the micropellet culture technique in presence
of Wnt-6 containing conditioned medium (CM). CM was obtained after
incubation of a chondrogenic medium consisting of DMEM supplemented
with ITS, proline, ascorbic acid and sodium pyruvate for 48h on conﬂuent
NIH-3T3 cells stably transfected to secrete Wnt-6. As controls, CM from
NIH-3T3 cells or BMP-2 containing medium was used. Similar conditions
were used to obtain CM with osteogenic or adipogenic media. After 21 days,
quantitative RT-PCR was performed on total RNA to detect the expression
of markers speciﬁc for each lineage and staining speciﬁc for proteoglycans,
mineralization or lipid droplets was performed. Western blotting with anti-
β-catenin, anti-JNK or anti-PKC antibodies was performed after migration
and transfer on nitrocellulose membranes of 20 μg total proteins extracted
from pellets after a time course exposure to the different CM.
Results: Pellet culture of murine MSCs in presence of NIH-derived CM or
chondrogenic medium alone did not up-regulate the chondrocytic markers.
On the contrary, Wnt-6 containing CM was suﬃcient to induce the differ-
entiation of MSCs into chondrocytes as shown by the induction of collagen
type IIB, aggrecan and COMP and a positive staining for proteoglycans.
The expression levels of the transcripts were lower than those induced by
BMP-2. However, contrary to BMP-2, we observed the lack of induction of
the hypertrophic markers collagen type X and alkaline phosphatase when
MSCs were cultured in Wnt-6 CM. Interestingly, in osteogenic or adipogenic
conditions, MSCs did not up-regulate the markers speciﬁc for osteoblasts or
adipocytes and rather decreased their expression level. The up-regulation
of chondrocytic markers by Wnt-6 was associated with a lack of induction
of the β-catenin or JNK pathways and preliminary results suggest that PKC
signalling may be induced.
Conclusions: Our results suggest that Wnt-6 is one new chondrogenic
factor suﬃcient to speciﬁcally induce the generation of chondrocytes
and inhibiting their terminal differentiation. Preliminary results suggest
that Wnt-6 might induce the PKC-dependent pathway to activate the
chondrocyte-speciﬁc genes.
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Purpose: Human bone marrow stromal cells (hBMSCs) are experimentally
being used in patients as a cell-based therapy for cartilage repair. To verify
the safety and eﬃcacy of such approaches it is necessary to determine the
fate of these implanted cells. Cell labeling using superparamagnetic iron
oxides (SPIOs) enables non-invasive in vivo cell tracking by MRI, and has
already been used in a clinical setting in various ﬁelds. In this study we de-
scribe a major step towards application of SPIO-labeling for cell tracking in
clinical cell-based cartilage repair approaches. We investigated the safety,
intra-articular MRI traceability and the possibility of SPIO re-uptake of this
cell tracking technique.
Methods: Safety: hBMSCs from three donors were labeled in triplicate
samples with ferumoxides (Endorem®)-protamine sulphate complexes at
doses ranging from 0 - 250 μg iron/ml. After incubation for 24 hours, cell
viability was assessed using a trypan blue exclusion assay. Subsequently,
metabolic cell activity was quantiﬁed using the AlamarBlue® assay up to
seven days after labeling. Chondrogenic capacity of hBMSCs labeled with
100 μg/ml SPIO was evaluated using thionine staining and collagen type II
immunohistochemistry.
Intra-articular imaging: SPIO-labeled hBMSCs (100,000 to 5,000,000 cells)
were injected ex vivo in pig knees, to mimic a clinically relevant sized
model. Furthermore, SPIO-labeled cells (10,000 - 1,000,000 per 75 μl) were
seeded in cartilage defects in vitro. Scanning was performed on a clinical
3.0 T MRI scanner.
SPIO re-uptake: To study possible SPIO re-uptake by synovial cells, viable
and dead GFP-SPIO double-labeled chondrocytes were seeded on human
synovium explants. After co-culturing for ﬁve days, samples were harvested
and analyzed using ﬂuorescence- and light microscopy.
Results: Safety: SPIO labeling resulted in labeling eﬃciencies of ± 95% and
did not impair cell viability or subsequent cell activity at any dose. SPIO-
labeled hBMSCs produced amounts of glycosaminoglycan and collagen type
II comparable to unlabeled control cells.
Intra-articular imaging: All SPIO-labeled cell dosages, both intra-articularly
injected and cells seeded in cartilage defects, were visualized by MRI (Fig.
1). Cell-dose dependent signal voids were observed, and cells could be
clearly differentiated from anatomical structures. SPIO-labeled cells seeded
in cartilage defects could be quantiﬁed using a T2* mapping MRI technique.
SPIO re-uptake: GFP+-SPIO+ cells, indicating originally seeded cells, were
seen in samples containing live cells. GFP--SPIO+ cells, indicating SPIO
re-uptake by synovial cells, were found in samples containing dead cells.
Conclusions: hBMSC labeling with SPIO particles is feasible, without
leading to negative effects on cell viability, subsequent metabolic cell ac-
tivity or chondrogenic differentiation. SPIO-labeled cells can be visualized
intra-articularly by MRI and quantiﬁed when seeded in a cartilage defect.
Although possible SPIO re-uptake by host cells has to be taken into account,
we showed promising results for the use of SPIO labeling for cell tracking
in clinical cartilage repair. This approach provides the extra advantage to
simultaneously track cells and evaluate cartilage repair in one MRI session.
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Purpose: Synovial membrane mesenchymal stem cells (MSCs) have been
demonstrated to be a good source of cells for the study of cartilage tissue
engineering. Multiple stem cells markers have been found by ﬂow cytom-
etry and immunoﬂuorescence in MSCs from human synovial membrane
pools. In this study we analyzed the chondrogenic potential of subpopula-
tions of MSCs derived from human synovial membranes enriched for CD73,
CD106 and CD271 markers.
Methods: Subpopulations of human synovial membrane MSCs enriched for
CD73, CD106 and CD271 markers were isolated using a cytometry sorter
and characterized by ﬂow cytometry for MSC markers. The expression
of Sox9, Nanog and Runx2 genes by these cells was measured by re-
verse transcriptase-polymerase chain reaction. The chondrogenesis of each
subpopulation was assessed by culturing the cells in a deﬁned medium
to produce spontaneous spheroid formation and differentiation towards
chondrocyte-like cells. The examination of the spheroids by histological
and immunohistochemical analyses for collagen type II (COL2), aggrecan,
collagen type I (COL1), metalloprotease 13 (MMP13) and collagen type
X (COLX) levels were performed to assess their chondrogenesis capacity.
The adipogenesis and osteogenesis potential of each subpopulation was
determined using commercial media; the resulting cells were stained with
oil red O or red alizarin to test the degree of differentiation.
Results: The subpopulations had different proﬁles of cells positive for
the MSC markers CD44, CD69, CD73, CD90 and CD105 and showed dif-
ferent expression levels of the genes Sox9, Nanog, Runx2 involved in
chondrogenesis, undifferentiation and osteoblastogenesis, respectively. Im-
munohistochemical analysis demonstrated that COL1, COL2, COLX, MMP13
and aggrecan were expressed in the spheroids as soon as 14 days of culture.
The CD271+ subpopulation expressed the highest levels of COL2 staining
